Recruiting Ankylosing Spondylitis Studies in Erlangen
About Ankylosing Spondylitis Clinical Trials in Erlangen
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 1 ankylosing spondylitis clinical trials recruiting participants in Erlangen, BAVARIA. These studies are seeking a combined 20 participants. Research is being sponsored by EspeRare Foundation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Erlangen — FAQ
Are there ankylosing spondylitis clinical trials in Erlangen?
Yes, there are 1 ankylosing spondylitis clinical trials currently recruiting in Erlangen, BAVARIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Erlangen?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Erlangen research site will contact you about next steps.
Are clinical trials in Erlangen free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Erlangen studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 1 active trials in Erlangen are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov